Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men - 25/08/11
, Anwar T Merchant, DMD, MPH, ScD a, Eric B Rimm, ScD a, b, c, Walter C Willett, MD, DrPH a, b, c, Meir J Stampfer, MD, DrPH b, c, Frank B Hu, MD, PhD a, b, cAbstract |
Purpose |
To assess the relation between the duration of diabetes and the risk of peripheral arterial disease among men.
Methods |
A total of 48,607 men in the Health Professionals Follow-up Study who returned a questionnaire in 1986 were followed for 12 years. Peripheral arterial disease (intermittent claudication or surgery for peripheral arterial diseases in the lower extremities) was ascertained by biennial questionnaire and confirmed by medical record review. Diabetes status and other cardiovascular risk factors were also ascertained by biennial questionnaire.
Results |
During follow-up (534,588 person-years), we documented 387 cases of peripheral arterial disease. After adjusting for cardiovascular risk factors, the relative risk of developing peripheral arterial disease among men with diabetes compared with men without diabetes was 2.61 (95% confidence interval [CI]: 1.98 to 3.45). Compared with men without diabetes, the relative risk of peripheral arterial disease among men with diabetes increased with duration of disease, even after adjusting for cardiovascular risk factors: 1.39 (95% CI: 0.82 to 2.36) for 1 to 5 years of diabetes, 3.63 (95% CI: 2.23 to 5.88) for 6 to 10 years, 2.55 (95% CI: 1.50 to 4.32) for 11 to 25 years, and 4.53 (95% CI: 2.39 to 8.58) for >25 years of diabetes (P for trend ≤0.0001).
Conclusion |
These results indicate that duration of type 2 diabetes is associated strongly with the risk of developing peripheral arterial disease.
Le texte complet de cet article est disponible en PDF.Keywords : peripheral arterial disease, diabetes, cohort
Plan
 | This study was supported by research grants HL35464 and CA55075 from the National Institutes of Health, Bethesda, Maryland, and a research grant from the American Diabetes Association. |
Vol 116 - N° 4
P. 236-240 - février 2004 Retour au numéro
Article précédent
- Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial
- Khaled Aljabri, Sharon E Kozak, David M Thompson
- Effects of sustained audit/feedback on self-reported health status of primary care patients
- Stephan D Fihn, Mary B McDonell, Paula Diehr, Stephen M Anderson, Katharine A Bradley, David H Au, John A Spertus, Marcia Burman, Gayle E Reiber, Catarina I Kiefe, Marisue Cody, Karen M Sanders, Mary A Whooley, Kenneth Rosenfeld, Linda A Baczek, Arthur Sauvigne
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?